Overland Jane, Abousleiman Jessie, Chronopoulos Andriana, Leader Natasha, Molyneaux Lynda, Gilfillan Christopher
Diabetes Centre, Royal Prince Alfred Diabetes Centre, Camperdown, NSW, Australia.
Diabetes Ther. 2014 Dec;5(2):557-65. doi: 10.1007/s13300-014-0092-9. Epub 2014 Dec 11.
The objective of this study was to determine whether people with type 1 diabetes are more likely to self-monitor their blood glucose (SMBG) as recommended by their diabetes health care professional using the Accu-Chek Mobile™ (F. Hoffmann-La Roche AG, Basel, Switzerland) monitoring system compared to the Freestyle Optium™ (Abbott, North Chicago, IL, USA).
Thirty-five participants with type 1 diabetes participating in a randomized cross-over study were assigned to monitor their blood glucose levels for a 3-month period using the Accu-Chek Mobile or the Freestyle Optium monitoring system and then to cross-over to the alternative device. After completion of the 6-month cross-over period, participants were invited to select their meter of choice and were followed for a further 3 months.
SMBG frequency increased in both groups but participants monitored significantly more often using the Accu-Chek Mobile meter (frequency SMBG/week median: 19 vs. 10, P = 0.04). After 3 months using each meter, 77% of participants indicated a preference for the Accu-Chek Mobile meter. Monitoring frequency in this group remained higher than baseline during the 3-month post-cross-over follow-up period.
Our results indicate that the Accu-Chek Mobile meter improves SMBG frequency. After experience of both systems, Accu-Chek Mobile was the meter of choice for the majority of participants in this study.
Roche Diabetes Care Unconditional Education Grant.
本研究的目的是确定与使用Freestyle Optium™（美国伊利诺伊州北芝加哥雅培公司）监测系统相比，1型糖尿病患者是否更有可能按照其糖尿病医疗保健专业人员的建议，使用Accu-Chek Mobile™（瑞士巴塞尔罗氏公司）监测系统进行自我血糖监测（SMBG）。
35名参与随机交叉研究的1型糖尿病患者被分配使用Accu-Chek Mobile或Freestyle Optium监测系统监测其血糖水平3个月，然后交叉使用另一种设备。在完成为期6个月的交叉期后，邀请参与者选择他们喜欢的血糖仪，并对其进行另外3个月的随访。
两组的自我血糖监测频率均有所增加，但使用Accu-Chek Mobile血糖仪的参与者监测频率明显更高（每周自我血糖监测频率中位数：19次对10次，P = 0.04）。在使用每种血糖仪3个月后，77%的参与者表示更喜欢Accu-Chek Mobile血糖仪。在交叉后3个月的随访期内，该组的监测频率仍高于基线水平。
我们的结果表明，Accu-Chek Mobile血糖仪可提高自我血糖监测频率。在体验了两种系统后，Accu-Chek Mobile是本研究中大多数参与者的首选血糖仪。
罗氏糖尿病护理无条件教育基金。
